| dataset,assay_id,property,endpoint_name,n_measurements,n_antibodies |
| FLAb2.0,024ad2a371ab07d5c4dc,thermostability,Tm (unspecified),8,8 |
| FLAb2.0,044ee92d75f37353fbb4,thermostability,Tm (°C),5,5 |
| FLAb2.0,09674a22c7a6ca8eeda1,thermostability,IgG Tm1 (°C),15,15 |
| FLAb2.0,0af4415c2bdfc64081df,thermostability,Tm1 (nanoDSF),86,86 |
| FLAb2.0,11d90c1d0afe09d9d721,pharmacokinetics,FcRn peak width (min),13,13 |
| FLAb2.0,17dfe00a98a21e215fc4,thermostability,IgG Tm1 (°C),28,27 |
| FLAb2.0,19077d50d3957bb26997,polyreactivity,APC MFI,15,5 |
| FLAb2.0,2608b61ff420c3d85a5e,aggregation,CIC column K,43,43 |
| FLAb2.0,2d0564aac2ac5f51120d,polyreactivity,Heme-induced binding (LysM),113,113 |
| FLAb2.0,2dba78ad15df8adc2d96,polyreactivity,Fitness score,6,2 |
| FLAb2.0,350b67a098ed0325c439,polyreactivity,BVP ELISA,136,136 |
| FLAb2.0,37b3ab59fbf37c50b046,polyreactivity,ELISA (readout unspecified),136,136 |
| FLAb2.0,3a984a5c1a82f18ef4eb,polyreactivity,Fatty-acid binding (FA),113,113 |
| FLAb2.0,3fed17d31a6e16bf499a,expression,HEK titer (mg/L),136,136 |
| FLAb2.0,404ad2a55626b2514fee,aggregation,Red-CGE purity (%),13,13 |
| FLAb2.0,419105de46ebaaf49ec5,polyreactivity,CIC retention time (min),136,136 |
| FLAb2.0,47167981dd65e8971cf3,aggregation,"SGAC-SINS AS100 ((NH4)2SO4, mM)",136,136 |
| FLAb2.0,47302bcb6f8125ad0a16,aggregation,CS-SINS (average),43,43 |
| FLAb2.0,4830618935f9c5ca6de4,aggregation,NR-CGE main peak (%),13,13 |
| FLAb2.0,4a579640ad0e15f4045b,polyreactivity,CIC retention time (min),14,14 |
| FLAb2.0,4ebd61da6d7238f75889,pharmacokinetics,Sequence pI,126,126 |
| FLAb2.0,50403676ab043c942b8f,aggregation,Heparin relative retention time (Rel RT),127,127 |
| FLAb2.0,65197acdc3d6aa268bba,pharmacokinetics,Heparin retention time (min),129,129 |
| FLAb2.0,665d0d3db3ec269c1061,thermostability,Tm (°C),14,14 |
| FLAb2.0,6babca0a56e8b9af4c29,aggregation,HIC relative retention time (RRT),13,13 |
| FLAb2.0,6ed7558706221c21169b,pharmacokinetics,FcRn retention time (min),13,13 |
| FLAb2.0,749dd9866ef71a9e598b,expression,Enrichment ratio (ER),10970,2803 |
| FLAb2.0,772e830ecb210d0354da,aggregation,SEC monomer (%),43,43 |
| FLAb2.0,79247afd3687a7e02048,pharmacokinetics,Tg32 half-life (h),43,43 |
| FLAb2.0,7fdec8b83a5f505e6850,polyreactivity,Anti-DNP binding,112,112 |
| FLAb2.0,8335b7ba29c8e659f669,thermostability,Tm (unspecified),7,7 |
| FLAb2.0,83a37f07f04722d4f227,pharmacokinetics,FcRn cellular recycling (ng/mL),43,43 |
| FLAb2.0,83ac1ba37a615bd6d834,aggregation,CSI-BLI delta response (nm),136,136 |
| FLAb2.0,85208561c341efdcb2b5,pharmacokinetics,FcRn relative retention time (Rel RT),131,131 |
| FLAb2.0,85a58e6764641111328f,aggregation,HIC retention time (min),43,43 |
| FLAb2.0,877b0e517d97eb382508,immunogenicity,ADA response (%),213,208 |
| FLAb2.0,8944dd647b919df662c4,aggregation,SEC main peak (%),13,13 |
| FLAb2.0,8a893a17ef3b98a11d70,polyreactivity,Heme-induced binding (FVIII),113,113 |
| FLAb2.0,92b75f8b8bd55f2c944c,polyreactivity,CIC retention time (min),5,5 |
| FLAb2.0,93c08e8830aa59301183,pharmacokinetics,Tg32 clearance (mL/h/kg),43,43 |
| FLAb2.0,94c855d62fc0d51b7fba,thermostability,Tm (unspecified),2,2 |
| FLAb2.0,97bc2ab5f4a765fdb9d8,expression,Enrichment ratio (ER),4275,4275 |
| FLAb2.0,a31d66b4febf37538f15,polyreactivity,Fe-induced binding (LysM),115,115 |
| FLAb2.0,a49d8eb65e98dbe5430d,aggregation,AC-SINS Δλmax (nm),136,136 |
| FLAb2.0,ab1ad43229ee20207d5d,polyreactivity,APC MFI,18,6 |
| FLAb2.0,afd4dea68793fc752928,polyreactivity,CIC retention time (min),5,5 |
| FLAb2.0,b52395b8f1426b9c6142,aggregation,cIEF main peak (%),43,43 |
| FLAb2.0,b9c153ac65caa3c04765,thermostability,Tm (unspecified),10,10 |
| FLAb2.0,bd837c1e8e6ab8153063,aggregation,AC-SINS shift (nm),13,13 |
| FLAb2.0,bdd9246ed6a5bbc9c7c3,expression,Expression titer (µg/mL),94,94 |
| FLAb2.0,becab0437d46fa143caf,polyreactivity,cELISA EC50 (pM),13,13 |
| FLAb2.0,c174c099e411e5bf442d,polyreactivity,Heme-induced binding (C3),113,113 |
| FLAb2.0,ccc6f4f932a3e03380db,thermostability,"Fab Tm (DSF, °C)",136,136 |
| FLAb2.0,cff2f1bc965798c3e768,pharmacokinetics,FcRn relative retention time (RRT),13,13 |
| FLAb2.0,d259563ff5197e4ac6ab,aggregation,HIC retention time (min),136,136 |
| FLAb2.0,d4a940c20f6bf6d7df8e,thermostability,Tm (unspecified),2,2 |
| FLAb2.0,d69d0210ceef07d03a69,polyreactivity,SMAC retention time (min),136,136 |
| FLAb2.0,d81315fa7a46bd8f71d9,polyreactivity,Heparin relative retention time (Rel RT),43,43 |
| FLAb2.0,d82b5d64996f73d7ad91,thermostability,DSF inflection point #1 (°C),13,13 |
| FLAb2.0,dac62d48096bd4d0be14,thermostability,DSF inflection point #2 (°C),13,13 |
| FLAb2.0,e0f1a9708aacd29e430b,polyreactivity,Heme binding,113,113 |
| FLAb2.0,e2e57e27c8a2e586e0c9,polyreactivity,CIC retention time (min),14,14 |
| FLAb2.0,e36c8ac57a268fdf03cd,aggregation,Accelerated stability slope,136,136 |
| FLAb2.0,e404d631f39508d9d6d8,thermostability,IgG Tm1 (°C),192,192 |
| FLAb2.0,e6d3c647f5b3ef8a67ed,aggregation,Fab pI,43,43 |
| FLAb2.0,e7a9187fce1b4980bf3d,aggregation,HIC retention time (min),97,97 |
| FLAb2.0,e9f988cd9b9982f0be79,polyreactivity,Anti-DNA binding (AU),13,13 |
| FLAb2.0,ee947bf16f9f0eefa368,polyreactivity,PSR score (0–1),43,43 |
| FLAb2.0,ef601318868dd91379a9,thermostability,DLS cumulant PDI,13,13 |
| FLAb2.0,f621e8144ffca75cfacc,polyreactivity,PSR score (0–1),136,136 |
| FLAb2.0,fc1aaa0dfd016f13aca8,aggregation,AC-SINS Δλmax (nm),43,43 |
| FLAb2.0,fd0e48db8dcaface0293,polyreactivity,Fe-induced binding (FVIII),115,115 |
| FLAb2.0,fd1df07aa3f7709e91a6,thermostability,"Fab Tm (DSF, °C)",43,43 |
| FLAb2.0,feb3a71ec3074dcc24f1,polyreactivity,Fe-induced binding (C3),115,115 |
| FLAb2.0,ff8fee3a9a8ad72644ff,thermostability,IgG Tm1 (°C),23,23 |
| PROPHET-Ab,PROPHET_01_Titer,expression,Titer,239,238 |
| PROPHET-Ab,PROPHET_02_Purity,aggregation,Purity,242,241 |
| PROPHET-Ab,PROPHET_03_SEC__Monomer,aggregation,SEC %Monomer,242,241 |
| PROPHET-Ab,PROPHET_04_SMAC,polyreactivity,SMAC,242,241 |
| PROPHET-Ab,PROPHET_05_HIC,aggregation,HIC,242,241 |
| PROPHET-Ab,PROPHET_06_HAC,pharmacokinetics,HAC,94,93 |
| PROPHET-Ab,PROPHET_07_PR_CHO,polyreactivity,PR_CHO,197,196 |
| PROPHET-Ab,PROPHET_08_PR_Ova,polyreactivity,PR_Ova,197,196 |
| PROPHET-Ab,PROPHET_09_AC-SINS_pH6.0,aggregation,AC-SINS_pH6.0,242,241 |
| PROPHET-Ab,PROPHET_10_AC-SINS_pH7.4,aggregation,AC-SINS_pH7.4,242,241 |
| PROPHET-Ab,PROPHET_11_Tonset,thermostability,Tonset,234,233 |
| PROPHET-Ab,PROPHET_12_Tm1,thermostability,Tm1,234,233 |
| PROPHET-Ab,PROPHET_13_Tm2,thermostability,Tm2,193,192 |
|
|
